VERA — Vera Therapeutics Inc. stock price and chart

Share this page

VERA

$27.88-2.42%

as of close, Oct 16, 2026

☾ AH $27.88 -2.42%

Vera Therapeutics Inc.Stock · HealthcareRussell 2000 0.09%Nasdaq Composite 0.006%US Stock Market 0.004%Russell 3000 0.003%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

Available history since May 18, 2021

VolumeEEEE

20212022202420252026

10.015.020.025.030.035.040.045.050.0010.0M20.0M$27.88

2026-10-16

Price$27.88

MA20$32.04

MA50$35.56

Vol1.3M

What would $1,000 invested in VERA be worth today? →

VERA returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $27.88
YTD price return: -44.94%
YTD total return: -44.94%
Next earnings: Nov 4, 2026
Market cap: 2B2021-06 282.1M2026-10 2B+612.6% over the window
Enterprise value: 1.6B
Shares outstanding: 72.1M2021-06 21.3M2026-06 72.1M+238.7% over the window
52W low: $23.05
52W high: $56.05
From 52W high: -50.26%
From 52W low: +20.95%
52W range: 15%

Volume

Rel volume: 0.56×
30D volume: 2.3M
30D $ vol: 74M

Fundamentals

EPS (ttm): -$5.892021-12 -$2.432026-06 -$5.89+142.5% over the window
FCF (ttm): -338.9M2020-12 -34.9M2026-06 -338.9M+870.9% over the window
FCF/share: -$4.702020-12 -$1.642026-06 -$4.70+186.7% over the window
Book value/share: $5.662020-12 -$4.202026-06 $5.66-234.7% over the window
ROE: -98.56%2021-12 -46.9%2026-06 -98.6%+110.3% over the window
ROA: -75.40%2020-12 -97.9%2026-06 -75.4%-23.0% over the window
Debt / equity: 0.18×2021-12 0.072026-06 0.18+160.8% over the window
Current ratio: 10.922020-12 22.552026-06 10.92-51.6% over the window

Growth (CAGR, ttm) · 10Y

Shares: +12.92%2025-06-30 → 2026-06-3063.8M → 72.1M (+12.9% total)+17.59%2023-06-30 → 2026-06-3044.3M → 72.1M (+62.6% total)+27.64%2021-06-30 → 2026-06-3021.3M → 72.1M (+238.7% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Book value/share: -22.89%2025-06-30 → 2026-06-30$7.34 → $5.66 (-22.9% total)+21.29%2023-06-30 → 2026-06-30$3.17 → $5.66 (+78.5% total)+5.49%2021-06-30 → 2026-06-30$4.33 → $5.66 (+30.6% total)n/a
Price: -8.63%2025-10-16 → 2026-10-16$30.51 → $27.88 (-8.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+39.17%2023-10-16 → 2026-10-16$10.34 → $27.88 (+169.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+13.18%2021-10-15 → 2026-10-16$15.01 → $27.88 (+85.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: -8.63%2025-10-16 → 2026-10-16$30.51 → $27.88 (-8.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+39.17%2023-10-16 → 2026-10-16$10.34 → $27.88 (+169.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+13.18%2021-10-15 → 2026-10-16$15.01 → $27.88 (+85.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -4.7×2021-06 -5.282026-10 -5.00-5.3% over the window
Fwd P/E: -7.0×
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 4.9×2021-06 3.062026-10 4.93+61.1% over the window
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: -16.87%2021-12 -4.2%2026-06 -11.0%+162.8% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 72.1M ÷ 63.8M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -12.92%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-12.92%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1.5B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -12.92%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($2B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2021-12 0.0%2026-06 0.0%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($2B). Same caveat as the cash buyback yield.: 0.00%2021-12 0.0%2026-06 0.0%

Vs own 10Y history

P/B: 52nd

Bar = where today’s multiple sits in VERA’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-2.42%

-6.69%

-12.24%

-28.73%

YTD

-44.94%

-8.62%

+85.74%

Financial statements

Open full VERA financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

VERA — Vera Therapeutics Inc. price, chart and key statistics